A new study from a group led by prominent industry critic Dr Pieter Cohen, MD, found a drug used in China sold in dietary supplements in the United States, in some cases at dosages apparently exceeding what’s used in clinical practice.
Legislation currently in the Senate could burden the hemp industry by setting an unrealistically low level of allowable THC, an industry group has said.
A new study has confirmed the extreme variability of Mucuna pruriens supplements for sale on the US market, once again calling into question the quality control and labeling of dietary supplements generally.
A failure on the part of Congress to pass an FDA fee reauthorization bill in a timely fashion could force furloughs among some Agency staff, according a memo from FDA Commissioner Robert Califf.
On Capitol Hill last week, hemp industry stakeholders and Congressional leaders frustrated by FDA’s lack of regulations for CBD and other hemp-derived compounds since the 2018 Farm Bill authorized commercial production of the crop, explored how the 2023...
The FDA appears to be moving ahead with a proposed rule to allow NAC (N-acetyl cysteine) as a dietary ingredient for use in supplements, according to a newly published guidance.
Through research, education, and grants, Realm of Caring is helping those in need of more information about cannabinoid therapies. The non-profit seeks to facilitate and encourage the mainstream acceptance of plant-powered therapies and serve healthcare...
An MLM that sells dietary supplements has been advised to remove claims relating to conditions such as autism, dementia and other disorders from the social media posts managed by distributors.
A new federal agency aimed solely at food safety would be created by a bill introduced recently by US Rep Rosa DeLauro (D-CT) and Sen Dick Durbin (D-IL).
A new study from a team headed by prominent industry critic Dr Pieter Cohen, MD, found that FDA warning letters did not prevent the subsequent sale of supplements with dodgy ingredients.
This year’s Dietary Supplement Regulatory Summit in Washington, DC, featured updates and insights from top FDA officials, including the Office of Dietary Supplement Programs along with top stakeholders and industry experts. Here are a few key takeaways...
The Council for Responsible Nutrition said that persistent problems with FDA’s NDI Draft Guidance means that few firms likely will file new notifications during the recently announced amnesty window.
A warning letter sent to Young Living, a multi level marketing company specializing in essential oils, underscores the importance of having a social media monitoring program in place to avoid running afoul of regulators.
The US Food and Drug Administration has sent warning letters to four companies marketing sexual enhancement supplements ostensibly based on honey but which contained undeclared ED drugs. The warning letters were part of a ongoing enforcement effort on...
The European Commission has published recommendations that try to clarify the definition of nanomaterials often used in nutrient delivery systems in nanoenabled foods and beverages.
Senator Richard Burr (R-NC), the ranking member of the Senate HELP Committee, has introduced a reauthorization of FDA User Fee Programs which does not include dietary supplement provisions.
FDA and FTC have issued four joint warning letters to kratom companies centered on opioid claims. It’s a move that comes on the heels of FDA rejecting an NDI filing on the ingredient for the sixth time.
Alkemist Labs claims many pesticide analyses conducted in the industry may be missing tests for some chemicals used as microbial agents and/or fungicides.
An elderberry product marketer has agreed to drop claims that its products contain elderberry in an advertising challenge lodged by Nature’s Way Brands, LLC, which has exposed elderberry adulteration in the past.
NDIs, drug preclusions, the CBD stalemate, actions at the State level, and an impending supply chain nightmare around plastics were just some of the highlights from a recent conference in New York City.
Whether they’re an investor, founder or spokesperson, public figures such as athletes and actors are benefitting from CBD’s therapeutic properties –and its ability to bring in the dough.
The American Herbal Products Association is urging members and stakeholders to contact lawmakers to oppose the mandatory product listing language that has been attached to a ‘must pass’ fee reauthorization bill.
A new study that sampled dozens of commercially available CBD products found detectable THC levels in 64% of them. Some levels were high enough to approach therapeutic thresholds or to potentially trigger drug test failures.
This year’s International Society of Sports Nutrition Annual Conference & Expo marked its 19th year promoting the science and application of evidence-based sports nutrition and supplementation. NutraIngredients-USA was there to hear about the latest...
In an ongoing market surveillance program, supplement manufacturer NOW has revealed a new trick spotted on Amazon to deceive consumers about what a product’s testing results actually mean.
Ingredient-specific actions, as evidenced recently by warning letters to 10 firms in the sports nutrition space, are important to FDA’s regulation of dietary supplements but additional actions are hampered by having to deal with problematic ingredients...
The head of the FDA’s Office of Dietary Supplement Programs suspects that remote regulatory assessments (RRAs) will continue even as regular facility inspections resume post-COVID, as the agency seeks to get a good picture of the compliance status of...
Pavlick joins the Consumer Healthcare Products Association’s regulatory and scientific affairs team after almost six years at the United Natural Product Alliance (UNPA).
Mandatory Product Listing can still be a good idea for industry, proponents maintain, even if the latest legislative iteration has failed to garner support from stakeholders.
Three trade organizations joined forces in opposing the FDA Safety and Landmark Advancement Act of 2022 (FDASLA), a fee authorization bill that includes provisions aimed at tightening dietary supplement regulations.
Branded ingredient supplier Taiyo has announced new certifications on its products that will better align them both with new Amazon and Canadian governmental requirements.
Amendments offered by Sen. Mitt Romney, R-UT, could soften some of the hardest edges in an FDA fee reauthorization bill that includes language meant to tighten the regulation of dietary supplements. But the bill still sets a very troubling precedent,...
A controversial California bill that seeks to place restrictions on the sale of some weight management supplements to minors has been amended but is still alive in the state's legislature.
Weight-loss testimonials "are not adequate substantiation" to prove diets work and specific food references require authorised health claims, the UK Advertising Standards Authority (ASA) has said in a guidance statement.
A bill to restrict some supplement sales has passed the Rhode Island State Senate by an overwhelming vote. The bill remains to be taken up by the state House before the legislature closes shop for the summer on June 30.
Authors of a bipartisan bill to reauthorize FDA user fees have included provisions bearing on dietary supplements, which has stirred up a hornets nest within the industry.
Lead scientist Richard van Breemen, along with his co-founder and CEO Jacob Crabtree joined us to discuss the research that caught the world’s attention.
The vertically-integrated supplier of hemp extracts and cannabinoid ingredients recently introduced HempNANO, its new concentrated nanoemulsion for water soluble applications.
A new report from the Centers of Disease Control has found that annual number of pediatric ingestions of melatonin reported to poison control centers increased 530% from 2012 to 2021.
While working at her father’s cigar company, Paola Fernandez invented a ‘natural’ alternative to tobacco-based rolling paper. In 2016, High Hemp was born and sells its flagship hemp wraps along with CBD gummies and tinctures. In under 5 years, Fernandez...
Alkemist Labs has announced a new quality and transparency program featuring validated, simplified test documents that can be shared with clients and customers. It’s the culmination of a seven year development process, the company said.
The US Federal Trade Commission is proposing an updated set of rules that would attempt to rein in the burgeoning use of phony reviews to hawk products online. They would also work to prevent the suppression of negative reviews
A mandatory product listing of the sort proposed in a recent bill sponsored by Sen. Dick Durbin, D-IL, would give an illusion of control of the dietary supplement marketplace without better protecting consumers, a prominent industry critic alleges.
FDA announced today that intends to exercise enforcement discretion on missing New Dietary Ingredient Notifications. The Agency also set up a new portal to allow companies to more easily come into compliance by filing the notifications that they should...
